Showing results (191-200 of 214) with videos related to
Sort By:
Pageof 22
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2014
Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapyJoshua R Bradish, Justin D Richey, Kristin M Post, et al.Human Pathology|May 30, 2021
Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testingOmer A M Saeed, Steven A Mann, Claudio Luchini, et al.Neurosurgery|July 24, 2025
A Dynamic Machine Learning Model to Predict Angiographic Vasospasm After Aneurysmal Subarachnoid HemorrhageRajeev D Sen, Margaret C McGrath, Varadaraya S Shenoy, et al.World Neurosurgery|September 26, 2021
Severe, Intolerable Fatigue Associated with Hyperresponse to ClopidogrelDavid I Bass, Christopher C Young, Min S Park, et al.Histopathology|July 19, 2012
KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomasRiley E Alexander, Antonio Lopez-Beltran, Rodolfo Montironi, et al.Neurosurgery|June 3, 2026
Safety and Efficacy of Expedited Discharge Protocols After Endoscopic Endonasal Pituitary Surgery: A Single-Center Cohort StudyDaniel N de Souza, Spencer Frome, Qing Wen, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 16, 2022
Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapyChristopher C Young, David I Bass, Michael J Cruz, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladderRiley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2022
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, Rola M Saleeb, Kiril Trpkov, et al.Nature Neuroscience|June 10, 2026
Cerebrovascular vulnerability and fibrosis in human brain aneurysmsJerry C Wang, Chang N Kim, Shubhang Bhalla, et al.Pageof 22